• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Trovagene Inc

+ Add to Watchlist

TROV:US

4.5400 USD 0.2000 4.61%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Trovagene Inc (TROV)

Open: 4.3800 Day's Range: 4.3200 - 4.5400 Volume: 79,434
Previous Close: 4.3400 52wk Range: 2.9700 - 7.1000 1-Yr Rtn: -11.84%

Stock Chart for TROV

No chart data available.
  • TROV:US 4.5400
  • 1D
  • 1M
  • 1Y
4.3400
Interactive TROV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TROV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6992
Est. EPS (USD) (12/2014) -0.8050
Est. PEG Ratio -
Market Cap (M USD) 85.82
Shares Outstanding (M) 18.90
30 Day Average Volume 82,258
Price/Book (mrq) 7.3051
Price/Sale (ttm) 316.9260
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TROV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TROV

Trovagene, Inc. is an applied genomics company. The Company is developing a non-invasive testing technology using transrenal nucleic acid (TrNA) markers for infectious diseases, prenatal testing, early detection of cancer, and monitoring of organ and cell transplantation.

Antonius P Schuh "Tony"Chief Executive OfficerStephen L Zaniboni "Steve"Chief Financial Officer
Mark ErlanderChief Scientific Officer
More Company Profile & Key Executives for TROV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil